deuterium has been researched along with Addison Disease and Cerebral Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeWitt, S; Hallakou-Bozec, S; Jacques, V; Kaur, N; Klett, E; Moller, DE; Monternier, PA; Nagaraja, TN; Parasar, P; Singh, J; Theurey, P | 1 |
| Kemp, S; Kulik, W; Mooyer, PA; Valianpour, F; Wanders, RJ | 1 |
2 other study(ies) available for deuterium and Addison Disease and Cerebral Sclerosis
| Article | Year |
|---|---|
Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Deuterium; Fatty Acids; Fatty Acids, Nonesterified; Inflammation; Mice; Mice, Knockout; Pioglitazone; PPAR gamma | 2022 |
Method for measurement of peroxisomal very-long-chain fatty acid beta-oxidation in human skin fibroblasts using stable-isotope-labeled tetracosanoic acid.
Topics: Adrenoleukodystrophy; Deuterium; Fatty Acids; Feasibility Studies; Fibroblasts; Humans; Isotope Labeling; Oxidation-Reduction; Peroxisomes; Skin; Spectrometry, Mass, Electrospray Ionization | 2004 |